La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Molecure Gestione
Gestione criteri di controllo 1/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Marcin Szumowski
Amministratore delegato
n/a
Compenso totale
Percentuale dello stipendio del CEO | n/a |
Mandato del CEO | no data |
Proprietà del CEO | 0.7% |
Durata media del management | 3.6yrs |
Durata media del Consiglio di amministrazione | 2.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?
Aug 20Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?
Apr 20We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate
Dec 01Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?
Jul 07Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth
Mar 10Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth
Aug 16OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem
Nov 04Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?
Feb 24Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?
Jan 02AMMINISTRATORE DELEGATO
Marcin Szumowski
no data
Mandato
zł548,043
Compensazione
Mr. Marcin Jan Szumowski, Ph D., is employed at Life Science Innovations Fund. He has been Chief Executive Officer and President of the Management Board at Molecure S.A. (formerly known as OncoArendi Thera...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Co-Founder | no data | zł548.04k | 0.70% PLN 1.8m | |
Co-Founder & VP of Research Chemistry | 12.6yrs | zł500.00k | 3.01% PLN 7.7m | |
CFO & Member of the Management Board | no data | zł414.20k | 0.20% PLN 524.5k | |
Chief Scientific Officer & Member of Management Board | 2.6yrs | zł376.64k | 0.11% PLN 287.1k | |
Member of Management Board & HR Director | 4.6yrs | zł345.44k | 0.034% PLN 88.2k | |
Co-Founder & Head of Medicinal Chemistry | no data | Nessun dato | Nessun dato | |
Chief Medical Officer & Member of Management Board | 1.6yrs | Nessun dato | Nessun dato | |
Head of CMC | 4.6yrs | Nessun dato | Nessun dato | |
Director of the Management Board Office | 2.6yrs | Nessun dato | Nessun dato |
3.6yrs
Durata media
Gestione esperta: Il team dirigenziale di MOC è considerato esperto (durata media dell'incarico 3.6 anni).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Vice Chairman of the Supervisory Board | 4.6yrs | zł140.98k | Nessun dato | |
Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Member of the Supervisory Board | 2.6yrs | zł63.46k | Nessun dato | |
Member of Supervisory Board | 2.6yrs | zł117.62k | 0.059% PLN 152.0k | |
Member of Supervisory Board | no data | zł112.78k | Nessun dato | |
Independent Chairman of Supervisory Board | 3.6yrs | zł197.37k | Nessun dato | |
Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Member of the Supervisory Board & Member of Scientific Advisory Board | 2.8yrs | zł117.62k | Nessun dato |
2.8yrs
Durata media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di MOC non è considerato esperto (durata media del mandato 2.8 anni), il che suggerisce un nuovo consiglio.